Cargando…

Utility of suPAR and NGAL for AKI Risk Stratification and Early Optimization of Renal Risk Medications among Older Patients in the Emergency Department

Diagnosis of acute kidney injury (AKI) based on plasma creatinine often lags behind actual changes in renal function. Here, we investigated early detection of AKI using the plasma soluble urokinase plasminogen activator receptor (suPAR) and neutrophil gelatinase-sssociated lipocalin (NGAL) and obser...

Descripción completa

Detalles Bibliográficos
Autores principales:	Walls, Anne Byriel, Bengaard, Anne Kathrine, Iversen, Esben, Nguyen, Camilla Ngoc, Kallemose, Thomas, Juul-Larsen, Helle Gybel, Jawad, Baker Nawfal, Hornum, Mads, Andersen, Ove, Eugen-Olsen, Jesper, Houlind, Morten Baltzer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471084/ https://www.ncbi.nlm.nih.gov/pubmed/34577543 http://dx.doi.org/10.3390/ph14090843

Ejemplares similares

Machine Learning to Identify Patients at Risk of Inappropriate Dosing for Renal Risk Medications: A Critical Comment on Kaas-Hansen et al [Letter]
por: Houlind, Morten Baltzer, et al.
Publicado: (2022)

Elevated suPAR Is an Independent Risk Marker for Incident Kidney Disease in Acute Medical Patients
por: Iversen, Esben, et al.
Publicado: (2020)

Soluble urokinase plasminogen activator receptor and decline in kidney function among patients without kidney disease
por: Iversen, Esben, et al.
Publicado: (2022)

Optimization of Nutrition And Medication (OptiNAM) for acutely admitted older patients: protocol for a randomized single-blinded controlled trial
por: Andersen, Aino L., et al.
Publicado: (2021)

Medicines Reconciliation in the Emergency Department: Important Prescribing Discrepancies between the Shared Medication Record and Patients’ Actual Use of Medication
por: Andersen, Tanja Stenholdt, et al.
Publicado: (2022)

The Perspective of Vitamin D on suPAR-Related AKI in COVID-19
por: Liao, Tzu-Hsien, et al.
Publicado: (2022)

High suPAR and Low Blood Eosinophil Count are Risk Factors for Hospital Readmission and Mortality in Patients with COPD
por: Håkansson, Kjell E J, et al.
Publicado: (2020)

Estimating Renal Function Following Lung Transplantation
por: Hornum, Mads, et al.
Publicado: (2022)

Predictive value of suPAR in AKI: a systematic review and meta-analysis
por: Huang, Yan, et al.
Publicado: (2022)

suPAR Cut-Offs for Risk Stratification in Patients With Symptoms of COVID-19
por: Altintas, Izzet, et al.
Publicado: (2021)

Comparison of 24‐hour urinary creatinine clearance and estimated glomerular filtration rate based on a panel of filtration markers in patients with chronic kidney disease
por: Iversen, Esben, et al.
Publicado: (2022)

Patterns of Multimorbidity and Differences in Healthcare Utilization and Complexity Among Acutely Hospitalized Medical Patients (≥65 Years) – A Latent Class Approach
por: Juul-Larsen, Helle Gybel, et al.
Publicado: (2020)

Sepsis and AKI in Clinical Emergency Room Patients: The Role of Urinary NGAL
por: Si Nga, Hong, et al.
Publicado: (2015)

Healthy lifestyles reduce suPAR and mortality in a Danish general population study
por: Haupt, Thomas Huneck, et al.
Publicado: (2019)

Does NGAL reduce costs? A cost analysis of urine NGAL (uNGAL) & serum creatinine (sCr) for acute kidney injury (AKI) diagnosis
por: Parikh, Amay, et al.
Publicado: (2017)

Availability of suPAR in emergency departments may improve risk stratification: a secondary analysis of the TRIAGE III trial
por: Schultz, Martin, et al.
Publicado: (2019)

Correction: Does NGAL reduce costs? A cost analysis of urine NGAL (uNGAL) & serum creatinine (sCr) for acute kidney injury (AKI) diagnosis
por: Parikh, Amay, et al.
Publicado: (2017)

IL-10 Combined with NGAL Has Diagnostic Value for AECOPD Combined with AKI
por: Wei, Bing, et al.
Publicado: (2020)

Longitudinal models for the progression of disease portfolios in a nationwide chronic heart disease population
por: Holm, Nikolaj Normann, et al.
Publicado: (2023)

NGAL: an emerging tool for predicting severity of AKI is easily detected by a clinical assay
por: Gabbard, Wes, et al.
Publicado: (2010)

POS-870 NGAL and microalbuminuria as AKi biomarkers in COVID-19 hospitalized patients with pneumonia
por: Rizo Topete MD, L., et al.
Publicado: (2022)

A Collaborative Deprescribing Intervention in a Subacute Medical Outpatient Clinic: A Pilot Randomized Controlled Trial
por: Aharaz, Anissa, et al.
Publicado: (2021)

Clinical Implementation of NGAL Testing to Improve Diagnostic Assessment of AKI Episodes in a Canadian Center
por: Côté, Jean-Maxime, et al.
Publicado: (2022)

The biomarkers suPAR and blood eosinophils are associated with hospital readmissions and mortality in asthma – a retrospective cohort study
por: Håkansson, K. E. J., et al.
Publicado: (2019)

suPAR to Risk-Stratify Patients With Malaria
por: Stefanova, Veselina, et al.
Publicado: (2022)

Prevalence and overlap of Disease Management Program diseases in older hospitalized patients
por: Juul-Larsen, Helle Gybel, et al.
Publicado: (2017)

Response to different furosemide doses predicts AKI progression in ICU patients with elevated plasma NGAL levels
por: Matsuura, Ryo, et al.
Publicado: (2018)

Urine Neutrophil Gelatinase-associated Lipocalin (NGAL) for Prediction of Persistent AKI and Major Adverse Kidney Events
por: Lumlertgul, Nuttha, et al.
Publicado: (2020)

Plasma neutrophil gelatinase associated lipocalin (NGAL) is associated with kidney function in uraemic patients before and after kidney transplantation
por: Magnusson, Nils E, et al.
Publicado: (2012)

Plasma neutrophil gelatinase-associated lipocalin (NGAL): A candidate biomarker to detect early acute kidney injury (AKI) for at-risk intensive care admissions
por: Nath, Chandan Kr, et al.
Publicado: (2022)

NGAL/hepcidin-25 ratio and AKI subtypes in patients following cardiac surgery: a prospective observational study
por: Elitok, Saban, et al.
Publicado: (2021)

The utility of neutrophil gelatinase-associated Lipocalin (NGAL) as a marker of acute kidney injury (AKI) in critically ill patients
por: Khawaja, Shabnum, et al.
Publicado: (2019)

Feasibility and Inter-Rater Reliability of Physical Performance Measures in Acutely Admitted Older Medical Patients
por: Bodilsen, Ann Christine, et al.
Publicado: (2015)

SuPAR - A future prognostic biomarker in emergency medicine
por: Østervig, Rebecca M, et al.
Publicado: (2015)

Kinetics of the soluble urokinase plasminogen activator receptor (suPAR) in cirrhosis
por: Garnæs, Emilie, et al.
Publicado: (2019)

suPAR is associated with risk of future acute surgery and post-operative mortality in acutely admitted medical patients
por: Meyer, Jeppe, et al.
Publicado: (2018)

Urine NGAL as a biomarker for septic AKI: a critical appraisal of clinical utility—data from the observational FINNAKI study
por: Törnblom, Sanna, et al.
Publicado: (2020)

Utility of plasma NGAL for the diagnosis of AKI following cardiac surgery requiring cardiopulmonary bypass: a systematic review and meta-analysis
por: Sharrod-Cole, Hayley, et al.
Publicado: (2022)

The Association of suPAR with Cardiovascular Risk Factors in Young and Healthy Adults
por: Wohlwend, Niklas Fabio, et al.
Publicado: (2023)

Use of the prognostic biomarker suPAR in the emergency department improves risk stratification but has no effect on mortality: a cluster-randomized clinical trial (TRIAGE III)
por: Schultz, Martin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_htptrnlf27hp88uosjfln6ti37